|
Q1 FY2015
As of Nov 30, 2014
|
Q4 FY2014
As of Aug 31, 2014
|
Q3 FY2014
As of May 31, 2014
|
Q2 FY2014
As of Feb 28, 2014
|
Q1 FY2014
As of Nov 30, 2013
|
Q4 FY2013
As of Aug 31, 2013
|
Q3 FY2013
As of May 31, 2013
|
Q2 FY2013
As of Feb 28, 2013
|
Q1 FY2013
As of Nov 30, 2012
|
Q4 FY2012
As of Aug 31, 2012
|
Q3 FY2012
As of May 31, 2012
|
Q2 FY2012
As of Feb 29, 2012
|
Q1 FY2012
As of Nov 30, 2011
|
Q4 FY2011
As of Aug 31, 2011
|
Q3 FY2011
As of May 31, 2011
|
Q1 FY2011
As of Nov 30, 2010
|
Q4 FY2010
As of Aug 31, 2010
|
Q3 FY2010
As of May 31, 2010
|
Q2 FY2010
As of Feb 28, 2010
|
Q1 FY2010
As of Nov 30, 2009
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Non-Current Assets | ||||||||||||||||||||
| Property and equipment, at cost, less accumulated depreciation and amortization | ||||||||||||||||||||
| Equity investment in Alliance Boots | ||||||||||||||||||||
| Alliance Boots call option | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Total Non-Current Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities & Equity | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Trade accounts payable | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Income taxes | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Non-Current Liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Total Non-Current Liabilities | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Preferred stock $.0625 par value; authorized 32 million shares, none issued | ||||||||||||||||||||
| Common stock $.078125 par value; authorized 3.2 billion shares; issued 1,028,180,150 at November 30, 2014, August 31, 2014 and November 30, 2013 | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Employee stock loan receivable | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Treasury stock, at cost; 82,537,852 shares at November 30, 2014, 77,793,261 at August 31, 2014 and 78,008,865 at November 30, 2013 | ||||||||||||||||||||
| Total Walgreen Co. Shareholders' Equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total Equity | ||||||||||||||||||||
| Total Liabilities and Equity | ||||||||||||||||||||
Loading...
